MedPath

A Prospective Observational Study Reviewing the Incidence of Nail Changes in Patients Receiving Docetaxel- Based Chemotherapy

Not Applicable
Conditions
Cutaneous toxicity
Breast cancer
Cancer - Breast
Registration Number
ACTRN12609000477224
Lead Sponsor
Dr Arlene Chan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped early
Sex
Female
Target Recruitment
150
Inclusion Criteria

Women with early breast cancer receiving adjuvent docetaxel based chemotherapy for at least 3 cycles of chemotherapy.

Exclusion Criteria

Serious intercurrent illness or psychological,sociological, geographical conditions which would preclude adequate follow up and compliance with the protocol.
Pre-existing nail conditions.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath